Open Access
Med Buccale Chir Buccale
Volume 19, Number 4, novembre 2013
Page(s) 227 - 233
Section Articles originaux / Original articles
Published online 10 September 2013
  1. Lefebvre J-L, Chevalier D. Épidémiologie des cancers des voies aérodigestives supérieures. Encyc Med Chir Oto-Rhino-Laryngol 2012;7:1-11. [Google Scholar]
  2. Dirix P, Nuyts S, Van den Bogaert W. Radiation-induced xerostomia in patients with head and neck cancer: a literature review. Cancer 2006;107:2525-34. [CrossRef] [PubMed] [Google Scholar]
  3. Sreebny LM, Valdini A. Xerostomia, a neglected symptom. Arch Intern Med 1987;7:1333-7. [CrossRef] [Google Scholar]
  4. Pignon T, Rafaramino F, Scalliet P. Cancer et sujets âgés. Prise en charge. Aspects décisionnels. Rev Med Interne 2000;21:765-76. [CrossRef] [PubMed] [Google Scholar]
  5. Prades J M, Schmitt T, Timoshenko A. Cancers de la langue. Encyc Med Chir Oto-Rhino-Laryngol 2004;1:35-55. [Google Scholar]
  6. Poissonnet G, Benezery K, Peyrade F, Bozec A, Bensadoun R-J, Marcy PY, Santini J, Dassonville O. Cancers ORL : les grands principes thérapeutiques. Presse Med 2007;36:1634-42. [CrossRef] [PubMed] [Google Scholar]
  7. Globocan 2008. Estimated cancer incidence, mortality, prevalence and disability-adjusted life years (DALYs) world wine in 2008. International Agency for Research on Cancer 2010. [Google Scholar]
  8. Li J, Shan Z, Ou G, Liu X, Zhang C, Baum BJ, Wang S. Structural and functional characteristics of irradiation damage to parotid glands in the miniature pig. Int J Radiat Oncol Biol Phys 2005;62:1510-6. [CrossRef] [PubMed] [Google Scholar]
  9. Ortholan C, Benezery K, Bensadoun RJ. Dose de tolérance à l’irradiation des tissus sains : les glandes salivaires. Cancer Radiother 2010;14:290-4. [CrossRef] [PubMed] [Google Scholar]
  10. Wijers OB, Levendag PC, Braaksma MM, Boonzaajer M, Visch LL, Schmitz PI. Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors. Head Neck 2002;24:737-47. [CrossRef] [PubMed] [Google Scholar]
  11. Atlan D, Hans S, Brasnu D, Housset M. Radiothérapie externe dans les cancers de la tête et du cou. Encycl Med Chir Oto-Rhino-Laryngol 2003;1:241-9. [Google Scholar]
  12. Coppes RP, Roffel AF, Zeilstra LJ, Vissink A, Konings AW. Early radiation effects on muscarinic receptor-induced secretory responsiveness of the parotid gland in the freely moving rat. Radiat Res 2000;153:339-46. [CrossRef] [PubMed] [Google Scholar]
  13. Coppes RP, Zeilstra LJ, Kampinga HH, Konings AW. Early to late sparing of radiation damage to the parotid gland by adrenergic and muscarinic receptor agonists. Br J Cancer 2001;85:1055-63. [CrossRef] [PubMed] [Google Scholar]
  14. Coppes RP, Vissink A, KoningS AW. Comparison of radiosensitivity of rat parotid and submandibular glands after different radiation schedules. Radiother Oncol 2002;63:321-8. [CrossRef] [PubMed] [Google Scholar]
  15. Bornstein M, Buser D, Filippi A. Concepts de prophylaxie et de traitement des effets secondaires de la radiothérapie de la région cervico-faciale. Rev Mens Suisse Odonto-Stomatol 2001;111:8-12. [Google Scholar]
  16. Meyer-Lueckel H, Kielbassa M A. Utilisation de succédanés salivaires chez les patients souffrant de xérostomie. Rev Mens Suisse Odonto-Stomatol 2002;112:1049-58 [Google Scholar]
  17. Nieuw Amerongen AV, Veerman ECI. Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. Support Care Cancer 2003;11:226-31. [PubMed] [Google Scholar]
  18. Seikaly H, Jha N, Harris JR, Barnaby P, Liu R, Williams D, McGaw T, Rieger J, Wolfaardt J, Hanson J. Long-term outcomes of submandibular gland transfer for prevention of postradiation xerostomia. Arch Otolaryngol Head Neck Surg 2004;130:956-61. [CrossRef] [PubMed] [Google Scholar]
  19. Maes A, Weltens C, Flamen P, Lambin P, Bogaerts R, Liu X, Baetens J, Hermans R, Van den Bogaert W. Preservation of parotid function with uncomplicated conformal radiotherapy. Radiother Oncol 2002;63:203-11. [CrossRef] [PubMed] [Google Scholar]
  20. Nutting C, Dearnaley DP, Webb S. Intensity modulated radiotherapy: a clinical review. Br J Radiol 2000;54:459-69. [CrossRef] [Google Scholar]
  21. Nutting CM, Morden JP, Harrington KJ, et al, on behalf of the PARSPORT trial management group. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011;12:127-36. [CrossRef] [PubMed] [Google Scholar]
  22. Gupta T, Agarwal JP, Jain S, Phurailatpam R, Kannan S, Ghosh-Laskar S, Murthy V, Budrukkar A, Dinshaw K, Prabhash K, Chaturvedi P, D’Cruz A. Three-dimensional conformal radiothe-rapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial. Radiother Oncol 2012;104:343-8. [CrossRef] [PubMed] [Google Scholar]
  23. Epstein JB, Robertson M, Emerton S, Phillips N, Stevenson-Moore P. Quality of life and oral function in patients treated with radiation therapy for head and neck cancer. Head Neck 2001; 23:389-98. [CrossRef] [PubMed] [Google Scholar]
  24. Kakoei S, Haghdoost AA, Rad M, Mohammadalizadeh S, Pourdamghan N, Nakhaei M, Bahador M. Xerostomia after radiotherapy and its effect on quality of life in head and neck cancer. Arch Iran Med 2012;15:214-28. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.